Prokarium is a biotechnology company with a vision to create the best platform for oral delivery of protein vaccines. Our synthetic biology platform Vaxonella makes vaccines more accessible to travellers and people living in rural and resource-poor areas
Prokarium attended the J P Morgan Healthcare conference and Biotech Showcase
Prokarium again visited San Francisco for a week of healthcare partnering, 12-16 January 2015. Ted Fjallman, CEO, presented at the Biotech Showcase on Monday the 12th.